Traumatic Cardiac Arrest and Trauma SimVR Training
Launched by MEDICAL UNIVERSITY OF VIENNA · Jun 4, 2024
Trial Information
Current as of June 12, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how effective virtual reality (VR) training is for teaching emergency department residents how to handle traumatic cardiac arrest, which is when a person's heart stops beating due to an injury. The main goal is to see if using VR can help these new doctors act faster in critical situations compared to traditional online learning methods. Participants will either use a new VR program or participate in e-learning that covers the same important skills.
To join the trial, participants must be first-year residents working in the emergency department and should not need eyeglasses to use the VR equipment. Unfortunately, people who are prone to motion sickness or are pregnant cannot participate. The trial is not yet recruiting participants, but once it starts, those who are eligible can expect to learn life-saving techniques in a cutting-edge, immersive way.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • first-year residents at the emergency department
- • only people who do not need eyeglasses for using VR
- Exclusion Criteria:
- • - pre-disposition for cybersickness (motion sickness, pregnancy, pre-existing cybersickness)
About Medical University Of Vienna
The Medical University of Vienna is a leading research institution dedicated to advancing healthcare through innovative clinical research and education. Renowned for its commitment to excellence in medical science, the university fosters interdisciplinary collaboration among researchers, clinicians, and academic professionals. Its clinical trials encompass a wide range of medical disciplines, aiming to develop cutting-edge therapies and improve patient outcomes. With state-of-the-art facilities and a strong emphasis on ethical standards, the Medical University of Vienna is at the forefront of transforming scientific discoveries into practical applications that enhance global health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vienna, , Austria
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported